CREDIT SUISSE AG/ - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 106 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$66,000
-31.2%
49,952
-4.5%
0.00%
Q1 2018$96,000
+11.6%
52,281
+28.7%
0.00%
Q4 2017$86,000
-46.9%
40,622
-44.0%
0.00%
Q3 2017$162,000
+305.0%
72,576
+211.4%
0.00%
Q2 2017$40,000
-7.0%
23,307
+35.3%
0.00%
Q1 2017$43,000
-36.8%
17,221
-61.9%
0.00%
Q4 2016$68,000
-18.1%
45,197
+38.9%
0.00%
Q3 2016$83,000
+43.1%
32,544
-14.5%
0.00%
Q2 2016$58,000
+163.6%
38,052
+233.1%
0.00%
Q1 2016$22,000
-93.9%
11,423
-90.2%
0.00%
Q4 2015$360,000
-23.7%
116,480
-17.4%
0.00%
-100.0%
Q3 2015$472,000
-32.1%
140,979
-24.7%
0.00%0.0%
Q2 2015$695,000
+157.4%
187,177
+157.6%
0.00%
Q1 2015$270,000
-27.4%
72,675
-13.9%
0.00%
Q4 2014$372,000
+1140.0%
84,378
+533.3%
0.00%
Q3 2014$30,000
-85.7%
13,324
-81.6%
0.00%
Q2 2014$210,000
-80.6%
72,421
-72.7%
0.00%
-100.0%
Q1 2014$1,084,000
+867.9%
265,613
+1001.3%
0.00%
Q4 2013$112,00024,1180.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 474,609$626,0000.55%
Kassirer Asset Management Corp 325,800$430,0000.28%
CORRADO ADVISORS, LLC 104,850$138,0000.08%
Artal Group S.A. 2,750,000$3,630,0000.08%
ROPES WEALTH ADVISORS LLC 100,000$132,0000.04%
MYCIO WEALTH PARTNERS, LLC 246,527$325,0000.03%
Palo Alto Investors LP 616,355$814,0000.03%
HOLLENCREST CAPITAL MANAGEMENT 172,570$228,0000.03%
LAU ASSOCIATES LLC 26,713$35,0000.02%
NATIXIS 3,438,529$4,539,0000.02%
View complete list of IDERA PHARMACEUTICALS INC shareholders